Tocilizumab Labeling with 99mTechnetium via HYNIC as a Molecular Diagnostic Agent for Multiple Myeloma-Reference-Cited by-同舟云学术

Tocilizumab Labeling with 99mTechnetium via HYNIC as a Molecular Diagnostic Agent for Multiple Myeloma

Published:2017-09-12 Issue:9 Volume:17 Page:
ISSN:1871-5206
Container-title:Anti-Cancer Agents in Medicinal Chemistry
language:en
Short-container-title:ACAMC

Author:

Camacho Ximena¹,Machado Camila Longo²,García Maria Fernanda¹,Fernádez Marcelo¹,Oddone Natalia³,Benech Juan³,Gambini Juan Pablo⁴,Cerecetto Hugo⁵,Chammas Roger³,Cabral Pablo⁵,Riva Eloisa⁶

Affiliation:

1. Departamento de Radiofarmacia, Centro de Investigaciones Nucleares, Facultad de Ciencias, Universidad de la República, Montevideo, Uruguay

2. Nuclear Medicine Medical Investigation Laboratory LIM43-Hospital das Clínicas da Faculdade de Medicina da Universidade de Sao Paulo - HCFMUSP, Brazil

3. Laboratorio de Senalizacion Celular y Nanobiologia, Instituto de Investigaciones Biologicas Clemente Estable, Montevideo, Uruguay

4. Centro de Medicina Nuclear, Hospital de Clinicas, Facultad de Medicina, Universidad de la Republica, Montevideo, Uruguay

5. Departamento de Radiofarmacia, Centro de Investigaciones Nucleares, Facultad de Ciencias, Universidad de la Republica, Montevideo, Uruguay

6. Clinica Hematologica. Hospital de Clinicas. Facultad de Medicina. Universidad de la Republica, Montevideo, Uruguay, Avenida Italia s/n, P.O. 11800, Montevideo, Uruguay

Publisher

Bentham Science Publishers Ltd.

Subject

Cancer Research,Pharmacology,Molecular Medicine

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Imaging of Melanoma VEGF-expressing Tumors through [^99mTc]Tc-HYNIC-Fab(Bevacizumab);Anti-Cancer Agents in Medicinal Chemistry;2024-11

2. Current and potential roles of immuno-PET/-SPECT in CAR T-cell therapy;Frontiers in Medicine;2023-06-27

3. 99mTc-HYNIC/Cy7-Fab(Bevacizumab): su empleo como agente de imagen en mieloma múltiple;Salud Militar;2023-05-29

4. 99mTechnetium- or Cy7-Labeled Fab(Tocilizumab) as Potential Multiple Myeloma Imaging Agents;Anti-Cancer Agents in Medicinal Chemistry;2021-07-26

5. Cy7-Tocilizumab/Fab(Tocilizumab): Near Infrared Fluorescence In Vivo Imaging of Multiple Myeloma;Blood;2018-11-29